Marshall Glesby

Summary

Affiliation: Cornell University
Country: USA

Publications

  1. pmc Effects of smoking on non-AIDS-related morbidity in HIV-infected patients
    Daniel K Shirley
    Division of Infectious Diseases, Weill Cornell Medical College, 525 E 68th St, Floor 24, New York, NY 10065, USA
    Clin Infect Dis 57:275-82. 2013
  2. pmc Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial
    Marshall J Glesby
    Department of Medicine, Weill Cornell Medical College, New York, New York, USA
    PLoS ONE 8:e61160. 2013
  3. ncbi request reprint Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study
    M J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, 525 E 68th St, New York, NY 10021, USA
    J Infect Dis 184:519-23. 2001
  4. ncbi request reprint Coronary heart disease in HIV-infected patients
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    Curr HIV/AIDS Rep 2:68-73. 2005
  5. ncbi request reprint Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers
    Marshall J Glesby
    Weill Medical College of Cornell University, New York, NY 10021, USA
    Clin Pharmacol Ther 78:143-53. 2005
  6. ncbi request reprint Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection
    Marshall J Glesby
    Weill Medical College of Cornell University, New York, NY 10021, USA
    J Infect Dis 191:686-93. 2005
  7. ncbi request reprint Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Acquir Immune Defic Syndr 37:1604-9. 2004
  8. ncbi request reprint Bone disorders in human immunodeficiency virus infection
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    Clin Infect Dis 37:S91-5. 2003
  9. pmc Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study
    Marshall J Glesby
    Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    Antivir Ther 15:571-7. 2010
  10. pmc Oxidant stress in HIV-infected women from the Women's Interagency HIV Study
    Marshall J Glesby
    Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    Antivir Ther 14:763-9. 2009

Research Grants

Detail Information

Publications42

  1. pmc Effects of smoking on non-AIDS-related morbidity in HIV-infected patients
    Daniel K Shirley
    Division of Infectious Diseases, Weill Cornell Medical College, 525 E 68th St, Floor 24, New York, NY 10065, USA
    Clin Infect Dis 57:275-82. 2013
    ....
  2. pmc Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial
    Marshall J Glesby
    Department of Medicine, Weill Cornell Medical College, New York, New York, USA
    PLoS ONE 8:e61160. 2013
    ..We aimed to determine if adding rosiglitazone to rhGH would abrogate the adverse effects of rhGH on insulin sensitivity (SI) and subcutaneous adipose tissue (SAT) volume...
  3. ncbi request reprint Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study
    M J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, 525 E 68th St, New York, NY 10021, USA
    J Infect Dis 184:519-23. 2001
    ..Corticosteroid use is an important risk factor for osteonecrosis, but its pathogenesis is likely multifactorial...
  4. ncbi request reprint Coronary heart disease in HIV-infected patients
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    Curr HIV/AIDS Rep 2:68-73. 2005
    ..Clinicians are advised to assess coronary heart disease risk in HIV-infected patients and to intervene to reduce the impact of modifiable risk factors...
  5. ncbi request reprint Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers
    Marshall J Glesby
    Weill Medical College of Cornell University, New York, NY 10021, USA
    Clin Pharmacol Ther 78:143-53. 2005
    ..We evaluated potential bidirectional pharmacokinetic interactions between calcium channel blockers and coadministered indinavir and ritonavir...
  6. ncbi request reprint Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection
    Marshall J Glesby
    Weill Medical College of Cornell University, New York, NY 10021, USA
    J Infect Dis 191:686-93. 2005
    ..We explored the strategy of initial immunostimulatory therapy with interleukin (IL)-2, followed by the addition of specific anti-HCV therapy, as a possible synergistic approach to treatment...
  7. ncbi request reprint Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Acquir Immune Defic Syndr 37:1604-9. 2004
    ..Herpes zoster occurs at all CD4 cell counts in HIV-infected adults. It was hypothesized that even in the era of highly active antiretroviral therapy (HAART), zoster risk is higher in HIV-infected than uninfected women...
  8. ncbi request reprint Bone disorders in human immunodeficiency virus infection
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    Clin Infect Dis 37:S91-5. 2003
    ..An improved understanding of the pathogenesis of these bone disorders should result in better preventative and therapeutic measures...
  9. pmc Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study
    Marshall J Glesby
    Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    Antivir Ther 15:571-7. 2010
    ..Limited data suggest that glycated haemoglobin (haemoglobin A1c; A1C) values might not reflect glycaemic control accurately in HIV-infected individuals with diabetes...
  10. pmc Oxidant stress in HIV-infected women from the Women's Interagency HIV Study
    Marshall J Glesby
    Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    Antivir Ther 14:763-9. 2009
    ..We hypothesized that oxidant stress is associated with plasma homocysteine concentration and risk factors for atherosclerosis in HIV-infected women...
  11. pmc Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women
    Carlos M Vaamonde
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    AIDS Res Hum Retroviruses 22:222-31. 2006
    ..We conclude that higher baseline CD4 count and lower HIV RNA level were associated with poor immunologic response to HAART in women with virologic suppression for at least 6 months. Persistent low level viremia may also contribute...
  12. pmc Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men
    Qing He
    Division of Gastroenterology, Department of Medicine, St Luke s Roosevelt Hospital Center, Columbia University, New York, NY, USA
    Antivir Ther 13:423-8. 2008
    ..This study investigates the interrelationships among fat distribution, hepatic lipid content, and insulin resistance in HIV-infected men...
  13. ncbi request reprint Brief report: efficacy and treatment-limiting toxicity with the concurrent use of lopinavir/ritonavir and a third protease inhibitor in treatment-experienced HIV-infected patients
    Nathalie C Casau
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA
    J Acquir Immune Defic Syndr 32:494-8. 2003
    ..05). Some HIV-infected patients concurrently treated with lopinavir/ritonavir and a third PI have viral suppression; many eventually discontinue therapy because of toxicity or virologic failure...
  14. pmc Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy
    Kristen M Marks
    Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA
    J Acquir Immune Defic Syndr 52:595-9. 2009
    ..Before potent antiretroviral therapy, thrombocytopenia was observed frequently. Little is known about risk factors for or severity and consequences of thrombocytopenia since establishment of highly effective therapy for HIV...
  15. ncbi request reprint Switching antiretroviral therapy: why, when and how
    Timothy Wilkin
    Weill Medical College, Cornell University, New York, USA
    IAPAC Mon 12:220-9. 2006
  16. ncbi request reprint Coronary heart disease in HIV-infected persons
    Marshall J Glesby
    Cornell Clinical Trials Unit, Weill Medical College of Cornell University, New York, USA
    AIDS Read 13:S15-9. 2003
    ..This article focuses on coronary heart disease in persons with HIV infection...
  17. ncbi request reprint Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection
    Craig W Hendrix
    Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 37:1253-62. 2004
    ..Overall, however, the average change in viral load across all patients was +0.03 log10 HIV RNA. Given these results, AMD3100 is not being further developed for ARV therapy, but development continues for stem cell mobilization...
  18. pmc Plasma homocysteine is not associated with HIV serostatus or antiretroviral therapy in women
    Farbod Raiszadeh
    Department of Medicine, St Luke s Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Acquir Immune Defic Syndr 51:175-8. 2009
    ..The effects of HIV serostatus and combination antiretroviral therapy (cART) on plasma homocysteine (HCY) are uncertain...
  19. ncbi request reprint Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection
    Jeffrey M Jacobson
    Department of Medicine, Beth Israel Medical Center and Albert Einstein College of Medicine, New York, New York 10003, USA
    J Infect Dis 188:1804-14. 2003
    ..Studies have reported that plasma human immunodeficiency virus type 1 (HIV-1) RNA levels and CD4+ lymphocyte counts in HIV-infected patients improved after treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF)...
  20. ncbi request reprint Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus
    Kristen M Marks
    Division of International Medicine and Infectious Diseases, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Infect Dis 192:1943-9. 2005
    ..The prevalence and significance of steatosis in patients coinfected with human immunodeficiency virus (HIV) and HCV are not well characterized...
  21. ncbi request reprint Dermatologic adverse effects of antiretroviral therapy: recognition and management
    Jay Luther
    Upstate Medical School, State University of New York, Syracuse, New York, USA
    Am J Clin Dermatol 8:221-33. 2007
    ..Management should be individualized based on the specific drug that is implicated and the severity of the reaction...
  22. pmc Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study
    Phyllis C Tien
    Department of Medicine, University of California, San Francisco, CA 94121, USA
    AIDS 23:1781-4. 2009
    ..Further follow-up is needed to clarify whether HIV/hepatitis C virus coinfection may be associated with a greater risk of carotid plaque...
  23. ncbi request reprint Case-control study of diabetes mellitus in HIV-infected patients
    Cecilia Yoon
    Department of Medicine, Weill Medical College, Cornell University, New York, NY 10011, USA
    J Acquir Immune Defic Syndr 37:1464-9. 2004
    ..Diabetes mellitus (DM) is more prevalent among patients with HIV infection. Besides protease inhibitors (PIs), other factors may contribute to the development of DM...
  24. ncbi request reprint A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087
    Judith A Aberg
    AIDS Clinical Trials Unit, Bellevue Hospital Center, New York University, New York, New York 10016, USA
    AIDS Res Hum Retroviruses 21:757-67. 2005
    ..Combination therapy with fenofibrate and pravastatin for HIV-related dyslipidemia provides substantial improvements in lipid parameters and appears safe, but is unlikely to achieve all NCEP targets for lipid levels...
  25. pmc Clinical manifestations associated with HTLV type I infection: a cross-sectional study
    Marina F Caskey
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    AIDS Res Hum Retroviruses 23:365-71. 2007
    ..9), periodontitis (OR = 10.0, 95% CI: 2.3-42.8), and dry oral mucosa (OR = 7.5, 95% CI: 1.7-32.8). HTLV-I infection is associated with a variety of clinical manifestations, which may occur in patients who have not developed myelopathy...
  26. pmc Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP
    Daniel J Morgan
    Department of International Medicine and Infectious Disease, Weill Medical College of Cornell University, New York, New York 10021, USA
    AIDS Res Hum Retroviruses 23:1499-504. 2007
    ..Conventional brain MRI frequently shows WM lesions in HTLV-I-infected individuals suggesting potential early central nervous system inflammation with rare development of progressive disease...
  27. ncbi request reprint Recombinant human growth hormone therapy in HIV-associated wasting and visceral adiposity
    Michael T Yin
    Division of Infectious Diseases, Columbia University Medical Center, NY, USA
    Expert Rev Anti Infect Ther 3:727-38. 2005
    ..The optimal treatment strategy, maintenance dose and duration of treatment have not been identified...
  28. pmc Incidence and risk factors for verrucae in women
    Jacqueline C Dolev
    University of California, San Francisco, California 94122, USA
    AIDS 22:1213-9. 2008
    ..To describe the incidence and risk factors for verrucae in HIV-infected and uninfected women...
  29. pmc Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study
    Michael J Silverberg
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 39:717-24. 2004
    ..The extended use of antiretroviral drugs among human immunodeficiency virus (HIV)-seropositive individuals underscores the need for a comprehensive evaluation of therapy-associated clinical symptoms...
  30. ncbi request reprint Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)
    Cecilia M Shikuma
    Hawaii AIDS Clinical Research Program, John A Burns School of Medicine, University of Hawaii at Manoa, Manoa Leihi Hospital, 3675 Kilauea Avenue, Honolulu, HI 96816, USA
    J Acquir Immune Defic Syndr 44:540-50. 2007
    ..To assess metabolic changes after initiation of protease inhibitor (PI)-sparing regimens in antiretroviral-naive patients...
  31. ncbi request reprint A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086
    Constance A Benson
    University of California, San Diego School of Medicine, San Diego, CA 92103, USA
    J Infect Dis 194:1309-18. 2006
    ..The role of structured treatment interruption (STI) before optimized antiretroviral therapy (ART) in patients with drug-resistant human immunodeficiency virus type 1 (HIV-1) is uncertain...
  32. ncbi request reprint Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management
    Greg T Allison
    AIDS 17:1-9. 2003
    ..Clinicians may help to prevent HIV-associated osteonecrosis by encouraging patients to limit their exposure to the established risk factors for the disease...
  33. ncbi request reprint Low bone mineral density, HIV infection, and women: fracture or fiction?
    Michael T Yin
    Clin Infect Dis 42:1021-3. 2006
  34. ncbi request reprint Editorial comment: drug-drug interactions, hepatitis C, and mitochondrial toxicity
    Marshall J Glesby
    AIDS Read 13:346-7. 2003
  35. pmc Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women
    Audrey L French
    CORE Center Stroger Cook County Hospital, Rush Medical College, Chicago, IL 60612, USA
    J Infect Dis 195:1437-42. 2007
    ..Anti-HBs levels were lower among anti-HCV-positive women. Isolated anti-HBc was rarely explained by occult HBV in this cohort but may be explained by the influence of viral coinfections on anti-HBs level or durability...
  36. ncbi request reprint Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection
    Ellen S Engelson
    Gastrointestinal Division, Obesity Research Center, New York 10025, USA
    J Acquir Immune Defic Syndr 30:379-91. 2002
    ..However, frequent adverse effects warrant controlled studies and careful patient monitoring, especially regarding glucose tolerance...
  37. ncbi request reprint Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult
    Michael P Dube
    Indiana University, Indianapolis, USA
    Clin Infect Dis 37:613-27. 2003
  38. ncbi request reprint Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Tria
    Bruce Shiramizu
    University of Hawaii, Honolulu, Hawaii 96816, USA
    J Acquir Immune Defic Syndr 33:329-35. 2003
    ..A larger study is needed to demonstrate whether SPECT parameters alone or with other markers can provide information on fibrosis with the clinical significance obtained through liver biopsy...
  39. ncbi request reprint Total hip arthroplasty in patients with human immunodeficiency virus infection: pathologic findings and surgical outcomes
    Craig R Mahoney
    Iowa Orthopedic Center, 411 Laurel St 3300, Des Moines, IA 50314, USA
    Acta Orthop 76:198-203. 2005
    ..The surgical outcomes of these HIV-positive patients were also reviewed...
  40. doi request reprint Prevention strategies for cardiovascular disease in HIV-infected patients
    James H Stein
    Circulation 118:e54-60. 2008
  41. ncbi request reprint Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis
    Luiz Henrique Guimaraes
    School of Medicine, Oregon Health and Sciences University, Portland, OR, USA
    J Infect Dis 195:142-8. 2007
    ..Helminth infections influence the clinical outcome of and immune response to certain immune-mediated diseases...
  42. ncbi request reprint Editorial comment: osteonecrosis in HIV-infected persons--does delayed diagnosis matter?
    Marshall J Glesby
    AIDS Read 18:132-3. 2008

Research Grants5

  1. Growth Hormone and Rosiglitazone for Visceral Adoposity
    Marshall Glesby; Fiscal Year: 2007
    ..If the results are as predicted, then combination therapy with rhGH and rosiglitazone may prove to be a highly effective treatment for visceral adiposity in HIV-infected patients. ..